Grifols S.A. Acquires Biotest AG
Mergers & Acquisitions
Grifols S.A. (NASDAQ: GRFS), a global healthcare leader, acquired Biotest AG (ETR: BIO), a provider of plasma proteins and biological drugs, for $2.2 billion.
Morrow Sodali acted as the information agent in this transaction.